MYD88 and neoplasm: Together, this data help explain the observed tumor-mediated cardiac dysfunction that is likely related to an upregulation in cardiac inflammation (MyD88) and autophagy (beclin-1) leading to metabolic perturbations and atrophy (p-FOXO1).